Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basket Study of vCTLs for Viral Infection in Immunocompromised Patients
NCT07873970Phase 1Not yet recruiting
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Nov 2026
- Primary completion
- Nov 2036
01
Overview
Phase 1, open-label, single-arm trial in cytomegalovirus infection (CMV), adenovirus infection, Epstein-Barr virus infection and 2 more, sponsored by Children's Hospital of Philadelphia. Primary endpoints: Occurrence of Grade 3 or higher acute graft-versus-host disease at 12 weeks and Occurrence of Grade 3 or higher infusion-related reactions at 12 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Conditions
cytomegalovirus infection (CMV)adenovirus infectionEpstein-Barr virus infectionBK virus infectionviral infection
Beyond the preview
Go deeper on NCT07873970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07873970.